CSF2 and neutropenia: Prophylaxis with granulocyte colony-stimulating factors (G-CSF) or granulocyte-macrophage colony-stimulating factors (GM-CSF) should be considered for risk stratification as G-CSF prophylaxis reduces the incidence of FN and bacterial infection by shortening the length of neutropenia [11].